A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples